Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 448

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 448
---
 the right to participate in up to 50% of future offerings for one year following the closing. We also agreed not to enter into an equity line of credit or similar agreement without the consent of the majority of the preferred shareholders. The transaction closed on October 10, 2024. Also on October 9, 2024, we entered into a securities purchase agreement with an accredited investor to satisfy $4.0 million of our debt by issuing 806,452 newly designated convertible NLS Preferred Shares at a purchase price of $4.96 per share. The NLS Preferred Shares have a conversion price of $4.96 per share. The investor was granted the right to purchase up to an additional $10.0 million worth of convertible NLS Preferred Shares starting six months after the closing and continuing as long as they own NLS Preferred Shares. The investor also has the right to participate in up to 50% of future offerings for one year following the closing. We agreed not to enter into an equity line of credit or similar agreement without the consent of the majority of the preferred shareholders. This transaction also closed on October 10, 2024. On October9, 2024, the Company and certain existing warrant holders entered into warrant amendment agreements, or collectively, the October Warrant Amendment, to amend those warrants issued by Company to such holders, collectively, to purchase up to 105,843 NLS Common Shares issued to such holders, or the Existing Warrants. The October Warrant Amendment makes certain adjustment to the definition of a “Fundamental Transaction” in Section 3(e) of the Existing Warrants. In exchange for the Amendment, the Company agreed to adjust the exercise price in the Common Warrants to CHF 0.80 and issued to the holders Pre -FundedWarrants to purchase up to 136,648 NLS Common Shares, or the October Pre -FundedWarrants. Each October Pre -FundedWarrant is exercisable for one Common Share at an exercise price of CHF 0.80 per share. The October Pre -FundedWarrants are immediately exercisable and may be exercised at any time until all of the October Pre -FundedWarrants are exercised in full. On October 10, 2024, the Company successfully implemented a restructuring measure by converting the claims of related party debt holders in the amount of $2,788,650 into 493,986 NLS Common Shares. This conversion was facilitated through an ordinary capital increase, providing the